SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-23-038334
Filing Date
2023-11-09
Accepted
2023-11-09 17:11:04
Documents
79
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q xfor-20230930.htm   iXBRL 10-Q 1362861
2 EX-10.1 ex-101q32023.htm EX-10.1 539223
3 EX-31.1 ex-311q32023.htm EX-31.1 9259
4 EX-31.2 ex-312q32023.htm EX-31.2 9247
5 EX-32.1 ex-321q32023.htm EX-32.1 5454
11 image_0a.jpg GRAPHIC 2079
12 xfor-20230930_g1.jpg GRAPHIC 71033
  Complete submission text file 0001628280-23-038334.txt   7282635

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xfor-20230930.xsd EX-101.SCH 50074
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xfor-20230930_cal.xml EX-101.CAL 62958
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xfor-20230930_def.xml EX-101.DEF 197217
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xfor-20230930_lab.xml EX-101.LAB 551405
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xfor-20230930_pre.xml EX-101.PRE 364184
73 EXTRACTED XBRL INSTANCE DOCUMENT xfor-20230930_htm.xml XML 865222
Mailing Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134
Business Address 61 NORTH BEACON STREET 4TH FLOOR BOSTON MA 02134 857-529-8300
X4 Pharmaceuticals, Inc (Filer) CIK: 0001501697 (see all company filings)

IRS No.: 273181608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38295 | Film No.: 231393715
SIC: 2836 Biological Products, (No Diagnostic Substances)